Patient Information

Choose your country or region in order to display more relevant content.

Select

Other country or region

Country

Language

Continue

Patient information

Whether you are due to get your placement soon, or you are currently in midst of your 16-week Program, we are here to help you through the journey.

Find out what you can expect at each step of your weight-loss journey

Get answers from our weight-loss experts

Access your data and statistics from your Allurion App

How to get your Allurion Connected Scale and Health Tracker set up

Access Allurion App

Download the Allurion App today to track your progress

Access here

Technical Support for Allurion Devices

Download our free resources for your Allurion Connected Scale, Health Tracker and Mobile App

Download

*As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
**The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.

R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
World Health Organization – Key facts on Obesity and overweight (who.int).
European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

Chat with Ally